TG Therapeutics has started enrolling adults with relapsing forms of MS for a Phase 3 trial testing a subcutaneous ...

Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is ...

Merus NV (($MRUS)) announced an update on their ongoing clinical study. Merus N.V. is conducting a Phase 3 clinical study titled ‘A Phase 3 Study ...

At Week 96 participants experienced even greater reductions in daily cornstarch intake while maintaining low levels of ...

Across the Phase 3 ROCKET program including ASCEND, the incidence of gastrointestinal ulceration events with rocatinlimab to date is less than 1 per 100 patient-years. The ASCEND study is ongoing and ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Tinlarebant has been granted Breakthrough Therapy, Fast Track, and Rare Pediatric Disease Designations in the U.S.; Orphan Drug Designation in the U.S., Europe, and Japan; and Pioneer Drug Designation ...

LYNX-3 is the second Phase 3 trial for this indication with Fast Track designation from the U.S. Food and Drug Administration (FDA) and is being conducted under a Special Protocol Assessment (SPA).

VIENNA — Ixekizumab (Taltz), an interleukin-17A inhibitor that's already approved for the treatment of psoriatic arthritis and axial spondyloarthritis in adults appears likely to be granted the same ...

Sentiment soured in May when Sanofi reported the failure of a phase 3 trial of its Regeneron-partnered IL-33 drug candidate ...

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...

UCHealth is preparing to launch a phase three study for another COVID-19 vaccine, the third coronavirus inoculation trial undertaken by the Colorado hospital giant since the pandemic began. This ...